글로벌 이가 치료 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

이가 치료 시장 분석

이가 치료 시장은 특히 학교에 다니는 어린이들 사이에서 이가 감염이 증가하는 유행에 힘입어 꾸준히 성장하고 있습니다. 이 시장은 샴푸, 로션, 이버멕틴 및 페르메트린과 같은 처방약을 포함한 일반 의약품 을 포함하여 이가의 살충제 내성에 대한 우려가 커지고 있는 다양한 솔루션을 제공합니다. 회사들은 건강을 의식하는 소비자들 사이에서 인기를 얻고 있는 무화학, 천연 대체 제품 개발에 주력하고 있습니다. 최근 개발에는 재감염 위험을 줄이기 위한 ParaPRO LLC 및 Arbor Pharmaceuticals 의 제품 출시가 포함됩니다 . 인지 캠페인이 증가하고 이가 치료 제형이 발전함에 따라 시장은 특히 이가 감염이 만연한 지역에서 상당한 성장을 이룰 준비가 되어 있어 새롭고 효과적인 솔루션에 대한 수요를 뒷받침하고 있습니다.

이가 치료 시장 규모

글로벌 이가 치료 시장 규모는 2023년에 1,063억 1,000만 달러로 평가되었으며, 2031년까지 1,779억 4,000만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 6.65%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

이가 치료 시장 동향

“ 무농약 처리법 개발”

이가 감염은 특히 어린이에게 흔한 문제로 남아 있기 때문에 이가 치료 시장은 진화하고 있습니다. 이 분야의 혁신에는 살충제 없는 치료 및 살충제 내성 이가 균주를 대상으로 하는 솔루션 개발이 포함됩니다. 주요 추세는 소비자가 화학 기반 제품의 잠재적 부작용에 대해 더 많이 알게 되면서 천연 무독성 이가 치료에 대한 수요가 증가하고 있다는 것입니다. 회사는 유해한 화학 물질 없이도 이를 효과적으로 퇴치하는 실리콘 기반 치료 및 효소 기반 제품과 같은 고급 제형을 출시하고 있습니다. 더 안전하고 효과적인 치료를 향한 이러한 변화 는 특히 이가 감염률이 높은 지역에서 시장 성장을 촉진하고 있습니다. 전반적으로 시장은 제품 다양성과 혁신이 급증하면서 보다 자연스러운 솔루션에 대한 소비자의 요구를 충족하고 있습니다.

보고서 범위 및 이가 치료 시장 세분화      

이가 치료 시장 정의

이가 치료는 일반적으로 사람의 머리카락과 두피에 기생하는 기생 곤충에 의해 발생하는 이가 감염을 없애는 데 사용되는 의학적 또는 치료 적 접근 방식을 말합니다. 일반적인 이가 유형에는 머릿니(Pediculus humanus capitis), 몸니(Pediculus humanus corporis), 음모니(Pthirus pubis)가 있습니다. 치료에는 페르메트린, 피레트린 또는 말라티온과 같은 활성 성분이 포함된 일반 의약품 또는 처방전 살충 샴푸, 로션 및 스프레이를 사용하는 것이 포함될 수 있습니다.

이가 치료 시장 동향

운전자

• 이가 감염 증가

The increasing prevalence of head lice infestations, especially among school-aged children, is a significant driver of the lice treatment market. Schools and daycare centers serve as common breeding grounds for these pests, leading to frequent outbreaks that can quickly spread among students. As awareness of lice infestations grows, parents and caregivers become more proactive in seeking effective treatment solutions. The visibility of outbreaks often prompts schools to implement policies for lice checks and treatment guidelines, further heightening awareness among families. Consequently, this increased concern translates into a surge in the demand for lice treatment products. Such dynamics create a robust market for effective and safe solutions, reinforcing the importance of addressing head lice infestations in educational settings.

• Rising Demand for Over-the-Counter Products

The availability of effective over-the-counter (OTC) lice treatment solutions plays a crucial role in driving the lice treatment market. Consumers appreciate the convenience of having readily accessible options for managing lice infestations, as these treatments can often be purchased without a prescription. This ease of access allows individuals and families to respond quickly to outbreaks, providing immediate relief from the discomfort and social stigma associated with lice. Furthermore, the variety of OTC products, which include shampoos, lotions, and sprays, caters to diverse preferences and needs, further enhancing consumer appeal. As awareness of lice infestations grows, so does the inclination to seek out these convenient treatments, resulting in increased sales and a thriving market for lice treatment solutions.

Opportunities

• Innovative Product Development

The lice treatment market is poised for growth through significant investments in research and development aimed at creating more effective and safer products. Companies have the opportunity to innovate by developing natural or organic formulations that cater to the increasing demand among health-conscious consumers seeking safer alternatives. These formulations can differentiate products in a competitive market, addressing consumer concerns about chemical exposure, especially for children. In addition, advancements in delivery systems, such as lice treatment shampoo or sprays that incorporate essential oils known for their insecticidal properties, can enhance efficacy and consumer appeal. By focusing on these innovations, companies can capture a larger market share and foster brand loyalty among consumers who prioritize health and safety in their purchasing decisions.

• Digital Marketing and E-commerce

The surge in online shopping has created a valuable opportunity for lice treatment brands to expand their reach and connect with a wider audience. With consumers increasingly turning to digital platforms for their purchasing needs, companies can leverage enhanced digital marketing strategies to improve brand visibility and drive sales. This trend has been particularly pronounced since the COVID-19 pandemic, as more individuals seek home care solutions, including effective lice treatments, that can be conveniently purchased from the comfort of their homes. By optimizing their online presence through social media, search engine marketing, and targeted advertising campaigns, lice treatment brands can effectively engage with consumers, address their concerns, and promote their products. Capitalizing on this shift toward e-commerce enhances sales potential and fosters a loyal customer base in an evolving retail landscape.

Restraints/Challenges

• Competition from Alternatives Treatments

The increasing popularity of alternative treatments and home remedies for lice infestations presents a significant challenge in the lice treatment market. Many consumers are turning to these options, often perceived as more natural or safer, despite a lack of scientific validation regarding their effectiveness. This trend can undermine confidence in traditional over-the-counter and prescription treatments, potentially leading to decreased sales for established brands. The rise of social media and online platforms further amplifies the visibility of these alternatives, making it easier for individuals to find and share anecdotal success stories. As a result, manufacturers of clinically tested lice treatments must work harder to educate consumers about the proven efficacy of their products while addressing the growing preference for non-traditional solutions.

•  Side Effects and Allergic Reactions

Some consumers may encounter side effects or allergic reactions when using chemical lice treatments, leading to reluctance in using these products. Common side effects can include scalp irritation, redness, itching, and, in more severe cases, systemic reactions. This discomfort can deter individuals from opting for chemical solutions, prompting them to seek alternative treatments, such as natural or herbal remedies. As awareness of these potential adverse effects grows, consumers are increasingly inclined to choose safer options, impacting the sales of traditional lice treatments. Consequently, the preference for alternative remedies poses a significant restraint on the lice treatment market, challenging manufacturers to innovate and improve the safety profile of their products to retain consumer trust and market share.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Lice Treatment Market Scope

The market is segmented on the basis of type, treatment, route of administration, dosage form, end-users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Pediculosis Capitis
• Pediculosis Corporis
• Pediculosis Pubis
• Others

Treatment

• Ivermectin
• Spinosad
• Permethrin
• Pyrethrin
• Others

Route of Administration

• Oral
• Topical
• Others

Dosage Form

• Tablets
• Shampoos
• Lotions
• Cream
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

 Lice Treatment Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, treatment, route of administration, dosage form, end-users, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the lice treatment market, driven by a growing population of children and the presence of prominent industry players. Furthermore, increasing healthcare spending in the region is expected to enhance market growth. This combination of factors positions North America as a key player in the lice treatment industry.

Asia-Pacific region is anticipated to experience significant growth from 2024 to 2031, primarily due to the presence of numerous generic manufacturers. In addition, improvements in healthcare infrastructure, coupled with rising incidences of lice infestations, are expected to drive market expansion. These factors collectively position the Asia-Pacific market for robust growth in the lice treatment sector.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Lice Treatment Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Lice Treatment Market Leaders Operating in the Market Are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Viatris Inc. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• AstraZeneca (U.K.)
• Johnson & Johnson Services, Inc. (U.S.)
• Bayer AG (Germany)
• Sun Pharmaceutical Industries Ltd. (India)
• Eli Lilly and Company (U.S.)
• Edenbridge Pharmaceuticals, LLC (U.S.)
• ParaPRO, LLC. (U.S.)
• Encube Ethicals Private Limited (India)
• GALDERMA (Switzerland)
• Alliance Pharma PLC (U.K.)
• Dr. Reddy's Laboratories Ltd. (India)
• Perrigo Company plc. (Ireland)

Latest Developments in Lice Treatment Market

• In October 2022, Alliance Pharmaceuticals launched a clinical trial in collaboration with South Florida Family Health and Research Centers to evaluate the safety and efficacy of Vamousse Spray 'n' Go. This trial compares the spray to a 1% Permethrin control shampoo for treating head lice infestations. The study aims to deliver crucial insights into the effectiveness of Vamousse Spray 'n' Go, potentially positioning it as a valuable alternative or enhancement to current lice treatment options
• In September 2022, the American Academy of Pediatrics updated its guidelines for the identification and treatment of head lice. The revisions included the introduction of new medications for effective treatment and presented a clear algorithm for managing affected patients. These updates aim to enhance clarity on diagnosis and treatment options for head lice infestations
• 2021년 8월, 특수 제약 회사인 ParaPRO는 Natroba(spinosad) 국소 현탁액 0.9% 출시를 발표하여 옴에 대한 최초의 FDA 승인을 받았습니다. 이 승인은 표적 국소 옵션을 제공함으로써 옴 치료에 있어 상당한 진전을 의미합니다. Natroba의 출시로 회사의 제품 포트폴리오가 향상되고 시장에서의 입지가 강화됩니다.
• 2021년 10월, Lice Clinics of America는 가열 공기 기술을 사용하여 750,000건의 머릿니 치료를 성공적으로 완료하여 놀라운 95%의 성공률을 달성했다고 발표했습니다. 이 혁신적인 접근 방식은 클리닉을 효과적인 머릿니 제거를 위한 선도적인 옵션으로 자리매김했습니다. 높은 성공률은 머릿니 감염에 맞서는 치료 방법의 효과를 강조합니다.     

SKU-54022